SHIP2の構造的な洞察は,その膜の規制メカニズムを明らかにします

Jyoti Gupta¹, Johanne Le Coq², Daniel Lietha³

¹Cell Adhesion Laboratory, UF Scripps, Jupiter, Florida, USA.

Protein science : a publication of the Protein Society

|February 12, 2026

まとめ

Srcホモロジー2ドメインに含まれるイノシトール-5フォスファタゼ2 (SHIP2) は,PIP3を脱酸化することによって細胞機能を調節する. その構造はドメイン関連と膜オリゴメリゼーションを明らかにし,SHIP2への洞察を提供している.

科学分野:

バイオケミストリーバイオケミストリー
分子生物学は分子生物学である.
細胞生物学細胞生物学

背景:

Srcホモロジー2ドメインを含むイノシトール-5フォスファタゼ2 (SHIP2) は,フォスホイノシチドシグナル伝達に不可欠です.
SHIP2は,増殖,結合,移動,生存などの細胞機能を調節する.
SHIP2の失調は,アルツハイマー病を含む癌や神経退行性疾患に関与しています.

研究の目的:

SHIP2.2の分子メカニズムを解明する.
SHIP2の冷凍電子顕微鏡 (cryoEM) 構造を決定する.
SHIP2の構造が,その機能と規制とどのように関係しているかを理解する.

主な方法:

低温電子顕微鏡 (cryogenic electron microscopy,cryoEM) を使用して,SHIP2の構造を解明する.
基板相互作用を研究するための生化学分析.
膜関連性を調査するための脂質相互作用研究.

主要な成果:

凍結EM構造は,SHIP2のプレックストリンホモロジーに関連するドメインと,そのC2およびフォスファタゼドメインとの間に予期せぬ関連性を明らかにした.
このドメインの配置は,特に高濃度のフォスホイノシチドでは,基板の相互作用を促進します.
SHIP2は細胞膜にオリゴーマーを形成することが観察されました.

結論:

SHIP2の活動は,そのドメインの組織と,膜脂質との相互作用によって調節される.
構造的な洞察は,さまざまな生理学的および病理学的状態におけるSHIP2の役割のメカニズム的理解を提供します.
この研究は,SHIP2を標的とした治療法に関するさらなる調査のための基礎を築きます.

キーワード:

さらに関連する動画

08:03

Advanced Self-Healing Asphalt Reinforced by Graphene Structures: An Atomistic Insight

Published on: May 31, 2022

5.7K

13:40

Live Cell Calcium Imaging Combined with siRNA Mediated Gene Silencing Identifies Ca2+ Leak Channels in the ER Membrane and their Regulatory Mechanisms

Published on: July 7, 2011

18.7K

関連する概念動画

02:02

Cis-regulatory Sequences

11.9K

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...

11.9K

02:02

Cis-regulatory Sequences

4.2K

01:15

Mechanisms of Membrane-bending

3.5K

The living membranes are flexible due to their fluid mosaic nature; however, their bending into different shapes is an active process regulated by specific lipids and proteins. The membrane bending can be transient as seen in vesicles or stable for a long time as in microvilli. Cells regulate the size, location, and duration of the membrane curvature.
Membrane bending can happen due to intrinsic changes in lipid composition or extrinsic association with different proteins. The proteins involved...

3.5K

00:59

Mechanisms of Membrane Domain Formation

3.9K

Different physical properties of lipids and proteins allow them to localize and form distinct islands or domains in the membrane. Some membrane domains are formed due to protein-protein interactions, whereas others are formed due to the presence of specific lipids such as sphingolipids and sterols—for example, large proteins, such as bacteriorhodopsin, aggregate and create distinct domains.
Another mechanism for membrane domain formation involves membrane proteins interacting with...

3.9K

01:23

Drug Absorption Mechanism: Passive Membrane Transport

7.0K

Passive transport is a method of drug absorption where small, lipid-soluble drugs can move across the cell membrane. This movement happens along the concentration gradient, which is a natural flow from higher to lower concentration areas. The speed at which the drug moves is directly related to its lipid–water partition coefficient. This means that the more a drug dissolves in lipids, the faster it diffuses or spreads throughout the body. It is important to note that most drugs are either...

7.0K

01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

6.3K

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...